Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
06/2000
06/06/2000US6071931 AT1 -receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys
06/06/2000US6071925 Antidepressants, anticonvulsants or antianxiety agents, also for treatment of memory loss in alzheimer's disease
06/06/2000US6071921 4-phenyl-7-arylquinoazolines; angiogenisis inhibitors and/or vascular permeability reducing effects in warm-blooded animals; anticarcinogenic and -arthritic agents; rheumatic diseases; vascular endothelium growth factor inhibitors
06/06/2000US6071906 Inhibits or modulates the inducible isoform of nitric oxide synthase over the the constitutive isoforms; antiarthritic, -diabetic, ischemic, thrombosis agents; cardiovascular disorders; toxic shock syndrome; autoimmune diseases
06/06/2000US6071899 Azetidinone derivatives for the treatment of atherosclerosis
06/06/2000US6071742 Coxsackie virus as a vector for delivery of anti-inflammatory cytokines
06/06/2000US6071722 Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1)
06/06/2000US6071720 Polynucleotide coding a polypeptide associated with ionic mobility; for the diagnosis, treatment or prevention of nervous system disorders, cardiovascular disorders and cancer; anticarcinogenic agents
06/06/2000US6071701 Detecting polynucleotide sequences which code polypeptide associated with inflammation; contacting nucleic acids with a polynucleotide sequence which codes inflammation polypeptide, allowing hybridization, detecting hybridization products
06/06/2000US6071523 Oral administering from squeezable container; storage stability, heat resistance; drug delivery
06/06/2000US6071514 Administering activated protein c and antiplatelet agent and/or anticoagulant
06/06/2000CA2198599C Salts of an anti-migraine indole derivative
06/06/2000CA2032900C The diastereoselective preparation of phosphinate esters
06/06/2000CA2029651C Tricyclic pteridinones and a process for their preparation
06/06/2000CA2002649C Cardioprotective tocopherol analogs
06/04/2000CA2291471A1 Lowering blood levels of lipoprotein(a)
06/02/2000WO2000031285A1 Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
06/02/2000WO2000031280A2 Use of plus-strand synthesis elements in retroviral vectors
06/02/2000WO2000031265A1 Urotensins ii of mammals and their uses
06/02/2000WO2000031263A2 Gtpase associated proteins
06/02/2000WO2000031248A1 Humanized monoclonal antibodies
06/02/2000WO2000031244A1 Compositions comprising angiostatin and kringle 5 region of plasminogen and methods of use thereof
06/02/2000WO2000031133A2 Potassium channel interactors and uses therefor
06/02/2000WO2000031123A2 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
06/02/2000WO2000031120A2 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis
06/02/2000WO2000031113A1 INTRACELLULAR TARGETED DELIVERY OF COMPOUNDS BY 70 kD HEAT SHOCK PROTEIN
06/02/2000WO2000031109A1 USE OF CORE 2 GlcNAc TRANSFERASE INHIBITORS IN TREATING INFLAMMATION
06/02/2000WO2000031100A2 Benzylmaltosides as inhibitors of smooth muscle cell proliferation
06/02/2000WO2000031096A1 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
06/02/2000WO2000031095A2 Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
06/02/2000WO2000031094A2 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
06/02/2000WO2000031093A2 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
06/02/2000WO2000031092A2 Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
06/02/2000WO2000031070A1 Novel benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same
06/02/2000WO2000031068A1 Polyhydroxylated heterocyclic derivatives as anti-coagulants
06/02/2000WO2000031067A1 Propanoic acid derivatives as integrin inhibitors
06/02/2000WO2000031065A1 Compounds having cytokine inhibitory activity
06/02/2000WO2000031063A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
06/02/2000WO2000031060A1 Scavenger compounds
06/02/2000WO2000031051A1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors
06/02/2000WO2000031050A1 Quinoline and quinoxaline compounds
06/02/2000WO2000031049A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors
06/02/2000WO2000031048A1 N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases
06/02/2000WO2000031047A1 Substituted 4-amino-2-aryl-cyclopenta[d]pyrimidines, their production and use and pharmaceuticalreparations containing same
06/02/2000WO2000031046A1 Novel acylguanidine derivatives, method for preparing same, application as medicines and pharmaceutical compositions containing them
06/02/2000WO2000031044A1 Iminoguanidine derivatives, preparation method, use as medicines
06/02/2000WO2000031039A1 Substituted benzo[de]isoquinoline-1,3-diones
06/02/2000WO2000031038A1 Quinoline derivatives as nk-2 and nk-3 receptor ligands
06/02/2000WO2000031037A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
06/02/2000WO2000031035A1 New manufacturing process
06/02/2000WO2000030673A1 Uses for eph receptor antagonists and agonists to treat vascular disorders
06/02/2000WO2000030671A2 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
06/02/2000WO2000030668A2 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
06/02/2000WO2000030665A1 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
06/02/2000WO2000030663A1 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of type 2 diabetes, the metabolic syndrome and associated cardiovascular diseases
06/02/2000WO2000030651A1 Use of staurosporine derivatives for treating ocular neovascular diseases
06/02/2000WO2000030627A2 Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis
06/02/2000WO2000030615A1 Method of preparing stable suspensions of insoluble microparticles
06/02/2000WO2000030588A2 Treatment of hypertension
06/02/2000WO2000030425A2 Method of using pon-1 to decrease atheroma formation
06/02/2000WO2000013710A3 Hydrogel compositions for the controlled release administration of growth factors
06/02/2000WO2000013703A9 Methods of treating hypertension and compositions for use therein
06/02/2000WO2000013691A3 3-deazaadenosine prevents atherosclerosis and graft vasculopathy
06/02/2000WO1999061097A9 Alpha emitting constructs and uses thereof
06/02/2000CA2352606A1 Urotensins ii of mammals and their uses
06/02/2000CA2352599A1 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
06/02/2000CA2352585A1 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of cardiovascular diseases
06/02/2000CA2352584A1 Quinoline and quinoxaline compounds
06/02/2000CA2352583A1 Quinoline and quinoxaline compounds as pdgf-r and/or lck tyrosine kinase inhibitors
06/02/2000CA2352510A1 Composition comprising soy protein, dietary fibres and a phytoestrogen compound and use thereof in the prevention and/or treatment of type 2 diabetes, the metabolic syndrome and associated cardiovascular diseases
06/02/2000CA2352477A1 Compositions comprising angiostatin and kringle 5 region of plasminogen and methods of use thereof
06/02/2000CA2352316A1 Treatment of hypertension
06/02/2000CA2352261A1 Quinoline and quinoxaline compounds as pdgf-receptor and/or lck tyrosine kinase inhibitors
06/02/2000CA2352144A1 Scavenger compounds
06/02/2000CA2352043A1 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
06/02/2000CA2351865A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
06/02/2000CA2351725A1 Substituted pyrazoles as p38 kinase inhibitors
06/02/2000CA2351630A1 Vector
06/02/2000CA2351365A1 Potassium channel interactors and uses therefor
06/02/2000CA2351361A1 Gtpase associated proteins
06/02/2000CA2351354A1 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis
06/02/2000CA2351348A1 Substituted benzo[de]isoquinoline-1,3-diones
06/02/2000CA2351311A1 Uses for eph receptor antagonists and agonists to treat vascular disorders
06/02/2000CA2351061A1 Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
06/02/2000CA2350969A1 Compounds having cytokine inhibitory activity
06/02/2000CA2350759A1 Benzylmaltotriosides as inhibitors of smooth muscle cell proliferation
06/02/2000CA2350758A1 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
06/02/2000CA2350755A1 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
06/02/2000CA2350753A1 Benzylmaltosides as inhibitors of smooth muscle cell proliferation
06/02/2000CA2350405A1 Method of using pon-1 to decrease atheroma formation
06/02/2000CA2350066A1 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
06/02/2000CA2349721A1 N-¬4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl|-acrylamide, an irreversible inhibitor of tyrosine kinases
06/02/2000CA2349290A1 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
06/02/2000CA2347940A1 Use of core 2 glcnac transferase inhibitors in treating inflammation
05/2000
05/31/2000EP1004584A2 Pyranoquinoline derivatives as inhibitors of cell proliferation
05/31/2000EP1004582A2 Pyridazino quinoline compounds
05/31/2000EP1004578A2 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives
05/31/2000EP1003783A2 Lipoprotein-regulating medicaments
05/31/2000EP1003780A1 Human f11 antigen: a cell surface receptor involved in platelet aggregation
05/31/2000EP1003776A1 Gene and amino acid sequences for novel transcription factor
1 ... 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 ... 1595